No Data
No Data
Stocks that moved and those that were traded in the front market.
*Japan Drugstore <3341> 2136 +400, particularly no signs of material surface, but rumors of restructuring may reignite. *TELUS Sky <3915> 2425 +425, the previous period had an upward landing and this period is expected to have significant profit growth. *Lacto Japan <3139> 3365 +503, substantial profit increase in the first quarter with good progress rate. *Doutor-Nichires Holdings <3087> 2785 +402, announced smooth financial results and a high level of Share Buyback. *GMO Internet <4784> 194.
Steady, supported by a pause in the rise of U.S. stocks and long-term U.S. interest rates.
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to show a stable performance. Yesterday, on the 14th, the U.S. stock market saw the Dow Inc rise by 312.08 points (+0.78%) to 40,524.79 dollars. The temporary exclusion of tariffs on Electronic Equipment and President Trump's indication of considering tariff reductions on Auto Parts supported stock prices. On the other hand, concern over the additional tariffs on Electronic Equipment hasn’t been completely dispelled, which limited the upside of stock prices. Today, buying is expected to dominate the Emerging Markets.
Globee, ABEJA and others.
<205A> Logos HD revises its forecast downward, now expecting an operating profit of 0.25 billion yen, down from 0.886 billion yen. <2334> Iore and ZUU <4387> form a capital and business alliance. <277A> Globing revises its forecast upward, now expecting an operating profit of 2.6 billion yen, up from 2.184 billion yen. <2934> J Frontier revises its forecast upward, now expecting an operating profit of 0.21 billion yen, up from a range of -2.00 to 0 billion yen. <3541> Agriculture Comprehensive Research Institute revises its forecast upward, now expecting an operating profit of 0.2 billion yen, up from 0.11 billion yen for the fiscal year ending in August 2025 to 2027.
Toho, for the fiscal year ending February 2025, operating profit increased by 9.2% to 64.6 billion yen, while Financial Estimates for February 2026 are projected to decrease by 11.9% to 57 billion yen.
Toho <9602> announced its financial results for the fiscal year ending February 2025, with operating revenue increasing by 10.5% compared to the previous period to 313.171 billion yen, and operating profit rising by 9.2% to 64.684 billion yen. For the fiscal year ending February 2026, the company plans operating revenue to decrease by 4.2% to 300 billion yen and operating profit to decrease by 11.9% to 57 billion yen. Additionally, the income from the distribution rights of the blockbuster movie "Godzilla -1.0" will drop, and the temporary closure of the Imperial Theatre due to reconstruction work will have an impact. This represents 5.63% of the total number of outstanding Stocks.
Asterisk: Presentation of financial results for the 2nd quarter of the fiscal year ending August 2025
Asterisk: Confirmation